Filter
361
Filtered Results: 361
Text search:
Virology
Featured
Recommendations
60
New Publications
84
Language
Document type
No document type
163
Guidelines
72
Studies & Reports
64
Manuals
20
Fact sheets
16
Strategic & Response Plan
12
Situation Updates
4
Training Material
3
Resource Platforms
3
Infographics
2
Brochures
1
Online Courses
1
Countries / Regions
Nigeria
19
India
12
Brazil
11
Global
10
Liberia
9
Zambia
9
South Africa
9
Latin America and the Carribbean
8
Africa
8
Sierra Leone
7
East and Southern Africa
7
West and Central Africa
7
Guinea
6
Congo, Democratic Republic of
6
Germany
6
Kenya
6
Rwanda
6
Bangladesh
6
Senegal
5
Nepal
5
Russia
5
Ghana
4
Burkina Faso
3
Syria
3
Western and Central Europe
3
Côte d’Ivoire / Ivory Coast
2
Ethiopia
2
Cameroon
2
Uganda
2
Zimbabwe
2
Philippines
2
Pakistan
2
South Sudan
2
Tanzania
2
China
2
North Macedonia
2
Bolivia
2
Middle East and North Africa
2
South–East Asia Region
2
Eastern Europe and Central Asia
2
Tajikistan
2
United Kingdom
2
Spain
2
Mali
1
Guinea-Bissau
1
Haiti
1
Afghanistan
1
Turkey
1
Indonesia
1
Mauritania
1
Malawi
1
Mozambique
1
Benin
1
Eswatini/ Swaziland
1
Colombia
1
Honduras
1
Ecuador
1
Botswana
1
Angola
1
Chile
1
Asia
1
Venezuela
1
Bulgaria
1
Georgia
1
Vietnam
1
North America
1
Uruguay
1
France
1
Mauritius
1
Portugal
1
Authors & Publishers
Publication Years
Category
Countries
122
Clinical Guidelines
53
Pharmacy & Technologies
38
Public Health
10
Key Resources
9
Women & Child Health
6
Capacity Building
3
Toolboxes
COVID-19
86
Rapid Response
49
HIV
38
Ebola
27
Zika
18
NTDs
16
Planetary Health
15
TB
10
AMR
7
Pharmacy
7
Caregiver
6
Polio
4
Specific Hazards
3
Conflict
2
Refugee
2
Health Financing Toolbox
2
Disability
1
Mental Health
1
Global Health Education
1
The purpose of this document is to provide interim guidance to laboratories and stakeholders involved in laboratory testing of patients who meet the definition of suspected case of pneumonia associated with a novel coronavirus identified in Wuhan, China.
19 March 2020
The speed of developing diagnostics for SARS-CoV-2, the causative agent of coronavirus disease 2019 (COVID-19), has been quite remarkable. Diagnostics have focused on nucleic acid amplification testing (NAAT) to identify infected individuals in acute-phase disease for timely implementation of mitiga...
8 January 2021
Sequencing enabled the world to rapidly identify SARS-CoV-2 and develop diagnostic tests and other tools for outbreak management. Continued genome sequencing supports the monitoring of the disease’s spread and evolution of the virus. Accelerated integration of genome sequencing int...
The growing understanding of how sequence information can contribute to improved public health is driving global investments in sequencing facilities and programmes. The falling cost and complexity of generating GSD provides opportunities for expanding sequencing capacity; however, challenges to wid...
The growing understanding of how sequence information can contribute to improved public health is driving global investments in sequencing facilities and programmes. The falling cost and complexity of generating GSD provides opportunities for expanding sequencing capacity; however, challenges to wid...
Direct acting antivirals (DAAs) have revolutionized treatment for hepatitis C. Combi-
nations of DAAs can cure infection with HCV in 12 weeks, are highly effective and
have limited side-effects. Affordability of DAAs has improved significantly, but access remains lim-
i...
Tests zur Detektion einer Infektion mit SARS-CoV-2 (neuartiges Coronavirus) sowie zum Nachweis von Antikörpern gehören zu den sog. In-vitro-Diagnostika (IVD). Das erstmalige Inverkehrbringen von In-vitro-Diagnostika auf dem deutschen Markt ist nach §§ 25 und 30 Medizinproduktegesetz (MPG) anzeig...
8 July 2020
Updated recommendations on simplified service delivery and diagnostics for hepatitis C infection
recommended
Policy Brief. 24 June 2022. This policy brief, one of two on the updated hepatitis C (HCV) guidelines, focuses on the new recommendations on simplified service delivery for a public health approach to HCV testing, care and treatment. These recommendations include decentralization, integration and ta...
To meet the need for laboratory diagnosis to be integrated in community care, the new 2022 Update describes point-of-care tests that can be performed both in district laboratories and peripheral healthcare facilities by non-specialist staff. Also included are recently developed self-tests.
Countries who have no testing capacity and national COVID-19 laboratories with limited experience on COVID-19 virus testing are encouraged to send the first five positives and the first ten negative COVID-19 samples to WHO reference laboratories providing confirmatory testing for COVID-19.
Updates ...
